Icecure Medical is trading 5.5% up at $3.05 in pre-market, extending its recent rebound from late-July lows amid broader risk-on sentiment and technical strength in smaller healthcare names.
- The move comes with no new company-specific news or filings, appearing driven by improving risk appetite across markets.
- Gains follow supportive equity futures and positive momentum in the broader small-cap healthcare sector.